The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Podcasts
GPO or Local/Self Contracting Series: Expectations of GPO Partners and Summary - Part 4
A thought-leader panel discussion about the role of GPOs within the changing healthcare landscape and the and the daily decision of using a GPO or
Podcasts
GPO or Local/Self Contracting Series: Compliance and Alignment - Part 3
A thought-leader panel discussion about the role of GPOs within the changing healthcare landscape and the and the daily decision of using a GPO or
Podcasts
GPO or Local/Self Contracting Series: Categories & Practices of Contracting Option Choices - Part 2
A thought-leader panel discussion about the role of GPOs within the changing healthcare landscape and the and the daily decision of using a GPO or
Podcasts
GPO or Local/Self Contracting Series: Introduction and the GPO Role - Part 1
Allen Archer, System Director of Supply Chain at Houston Healthcare, leads a thought-leader panel discussion about the role of GPOs within the chan
Podcasts
CQO and Nexera Member Successes Podcast
Nexera has incorporated Cost, Quality, and Outcomes (CQO) throughout their own organizational culture, and embeds that philosophy into their partne
Podcasts
Optimizing Supply Chain using UHF-RFID Technology
Lana Makhanik and Peter Fiorentino discuss discus why Beth Israel Deaconess Medical Center is breathing easier after they overhauled their inventor